普卡酶素CAS号18378-89-7

普卡酶素

¥605.00 ~¥7,319.00
1mg / 5mg / 25mg
1mg
江苏
永健医药
2025-12-17
我要询单 立即交流 查看联系方式
江苏永健医药科技有限公司
手机号: 17701422016
联系人: 韩经理
联系QQ: 3587493084
邮箱: 3587493084@qq.com
企业微信 企业微信
个人微信 个人微信
电话邮箱等咨询请告知是在960化工网上看到的,谢谢!
产品详情
中文名称:普卡酶素中文别名:普卡酶素
英文名称:CAS:18378-89-7
产品分类:抗生素纯度:≥95%
产品编号品牌纯度规格库存价格
A10732永健医药≥95%1mg询价605.00 元
A10732永健医药≥95%5mg询价1,755.00 元
A10732永健医药≥95%25mg询价7,319.00 元
标准名称:普卡霉素英文名称:Plicamycin
CAS:18378-89-7分子式:C52H76O24
分子量:1085.14545917511颜色与性状:由链霉菌Streptomyces tanashiensis或S.684号菌株培养液体中提取的抗生素。鲜黄色结晶
密度:1.48±0.1 g/cm3 (20 ºC 760 Torr),沸点:761.72°C (rough estimate)
熔点:181.5 ºC水溶性:
别名 光辉酶素,金霉酸|Mithramycin A|普卡霉素|光辉霉素
英文别名 MITHRAMYCIN|plicamycin|Mithracin|mithramycin a|Aureolic acid|18378-89-7|Mithramycinum|Mithramycine|Plicamycine|Plicamycinum|Mitramycin|Aurelic acid|CHEBI:31856|Antibiotic LA 7017|CHEMBL257619|NIJ123W41V|Mitramycine|Mitramycinum|Aurlelic acid|A-2371|Plicam
规格或纯度 ≥95%
英文名称 Plicamycin 生化机理 Anticancer antibiotic. Inhibits transcription and protein synthesis. Binds to DNA in native chromatin. Substrate of Pgp in MDR phenotypes.DNA and RNA polymerase inhibitor, DNA binding transcriptional inhibitor (Sp1 and Sp3). Shows antineoplastic activity.
储存温度 -20°C储存,充氩
运输条件 超低温冰袋运输 备注 如果有可能,您尽量在使用的当天配置溶液,并在当天使用完它。但是,如果您需要预先配制储备溶液,我们建议您将溶液等份保存在-20°C的密封小瓶中。通常,它们最多可以使用一个月。在使用前和打开样品瓶之前,我们建议您让您的产品在室温下平衡至少1小时。需要更多关于溶解度,用法和处理的建议吗?请访问我们的常见问题(FAQ)页面以获取更多详细信息。
产品介绍 Mithramycin A is an antibiotic DNA/RNA polymerase and DNA binding transcriptional inhibitor observed to facilitate TNF-α and Fas-ligand induced apoptosis. As a DNA binding transcriptional inhibitor, mithramycin A binds to GC rich sequences located in the minor groove of DNA and is noted to be reversible and Mg2+ dependent. Additionally reported to a block transcriptional activation of the SV40 promoter via competitive binding against Sp1 transcription factor to GC rich areas in the early promoter. Mithramycin A is noted to supress TNF-α induced expression of fractalkine (CX3CL1) mRNA in a dose-dependent manner and to act as an effective differentiation agent of HL60 promyelocytic leukemia cellsA polymerase inhibitor that binds to GC rich sequences located in the minor groove of DNA;DNA binding fluorescent dye. Until 2000 it was used to reduce high levels of plasma calcium; Used as an antineoplastic agent Mithramycin A is an antibiotic DNA/RNA polymerase and DNA binding transcriptional inhibitor observed to facilitate TNF-α and Fas-ligand induced apoptosis. As a DNA binding transcriptional inhibitor, mithramycin A binds to GC rich sequences located in the minor groove of DNA and is noted to be reversible and Mg2+ dependent. Additionally reported to a block transcriptional activation of the SV40 promoter via competitive binding against Sp1 transcription factor to GC rich areas in the early promoter. Mithramycin A is noted to supress TNF-α induced expression of fractalkine (CX3CL1) mRNA in a dose-dependent manner and to act as an effective differentiation agent of HL60 promyelocytic leukemia cells A polymerase inhibitor that binds to GC rich sequences located in the minor groove of DNA;DNA binding fluorescent dye. Until 2000 it was used to reduce high levels of plasma calcium; Used as an antineoplastic agent
公司简介

江苏永健医药科技有限公司成立于2012年6月,是一家专业从事天然产物活性成分研究与开发,同时提供植物成分高效分离纯化工艺解决方案的高科技企业。 

公司位于中国医药城,拥有2000平方米的研发中心和1000平方米的生产基地。现有员工50人,其中中高级职称10人,本科以上学历占比90%以上。购置了核磁共振(Bruker 400MHz)波谱仪、多台全自动分析高效液相色谱仪、制备型液相色谱仪等近两千万元仪器设备,是国内中药化学成分提取及中药对照品研制的重要力量之一。 

公司主要从事中药活性物质基础及中药新药的研究。迄今为止,公司累计对百余种常用中药进行了较为深入的研究,从中***了六百多种化学成分(每年增加100种左右),作为检测试剂(中药化学对照品)、新药研发原料等,提供给国家药检所、国内外数百家科研机构。 

近年来,公司在中药新药研发领域取得重大突破,从常用中药中提纯多个高活性单体化合物,申请了多项国内与国际专利。

企业认证:已认证企业性质:生产研发
主营产品:茴香酸对羟基苯乙酯 紫萁酮 槐定碱 山奈酚-3-O-葡萄糖鼠李糖苷 甲基麦冬黄酮B 供货范围:试剂
产品目录:16175 品牌:永健医药
已认证
生产研发
16175 
医药城三期g23栋6楼
进入店铺